Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Staropoli

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Intensive Care Medicine Experimental|November 26, 2025
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort studyTimothée Bruel, Isabelle Staropoli, Pierre Bay, et al.
Cell Reports. Medicine|April 26, 2021
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodiesJérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli, et al.
Journal of Virology|December 13, 2023
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1William Bolland, Vincent Michel, Delphine Planas, et al.
The Journal of Infectious Diseases|March 11, 2021
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Ludivine Grzelak, Aurélie Velay, Yoann Madec, et al.
Annals of the Rheumatic Diseases|January 13, 2022
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseasesJerome Hadjadj, Delphine Planas, Amani Ouedrani, et al.
Clinical Pharmacology and Therapeutics|October 5, 2023
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling AnalysisGuillaume Lingas, Delphine Planas, Hélène Péré, et al.
Plos Pathogens|April 19, 2021
Mechanisms of HIV-1 evasion to the antiviral activity of chemokine CXCL12 indicate potential links with pathogenesisMarie Armani-Tourret, Zhicheng Zhou, Romain Gasser, et al.
Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Nature Communications|February 14, 2023
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Intensive Care Medicine Experimental|November 26, 2025
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort studyTimothée Bruel, Isabelle Staropoli, Pierre Bay, et al.
Cell Reports. Medicine|April 26, 2021
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodiesJérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli, et al.
Journal of Virology|December 13, 2023
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1William Bolland, Vincent Michel, Delphine Planas, et al.
The Journal of Infectious Diseases|March 11, 2021
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2Ludivine Grzelak, Aurélie Velay, Yoann Madec, et al.
Annals of the Rheumatic Diseases|January 13, 2022
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseasesJerome Hadjadj, Delphine Planas, Amani Ouedrani, et al.
Clinical Pharmacology and Therapeutics|October 5, 2023
Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling AnalysisGuillaume Lingas, Delphine Planas, Hélène Péré, et al.
Plos Pathogens|April 19, 2021
Mechanisms of HIV-1 evasion to the antiviral activity of chemokine CXCL12 indicate potential links with pathogenesisMarie Armani-Tourret, Zhicheng Zhou, Romain Gasser, et al.
Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Nature Communications|February 14, 2023
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Pageof 7